➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Harvard Business School
Johnson and Johnson
Dow
Baxter

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

SUMATRIPTAN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Sumatriptan, and when can generic versions of Sumatriptan launch?

Sumatriptan is a drug marketed by Cipla, Florida, Lannett Co Inc, Perrigo Uk Finco, Aurobindo Pharma Ltd, Mylan, Sun Pharm, Antares Pharma Inc, Dr Reddys, Fresenius Kabi Usa, Hikma, Mylan Asi, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz Inc, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Zydus, Aurobindo Pharma, Corepharma, Dr Reddys Labs Inc, Fosun Pharma, Hikma Pharms, Orchid Hlthcare, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirty-nine NDAs.

The generic ingredient in SUMATRIPTAN is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.

Drug patent expirations by year for SUMATRIPTAN
Drug Prices for SUMATRIPTAN

See drug prices for SUMATRIPTAN

Drug Sales Revenue Trends for SUMATRIPTAN

See drug sales revenues for SUMATRIPTAN

Recent Clinical Trials for SUMATRIPTAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cambridge University Hospitals NHS Foundation TrustEarly Phase 1
PfizerPhase 1
Zagazig UniversityN/A

See all SUMATRIPTAN clinical trials

Medical Subject Heading (MeSH) Categories for SUMATRIPTAN

US Patents and Regulatory Information for SUMATRIPTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076976-001 Aug 10, 2009 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Aurobindo Pharma SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078327-001 Aug 10, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 077163-002 Nov 2, 2009 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sun Pharm Inds SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078295-002 Aug 10, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma Pharms SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078298-002 May 21, 2013 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 077744-002 Aug 10, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Orchid Hlthcare SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078284-003 Aug 10, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Harvard Business School
Johnson and Johnson
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.